Abnormal Cd4 Cd8 Ratio C4531154
This test compares two types of infection-fighting cells in the blood. An abnormal ratio may occur with infections, immune disorders, or other conditions.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Recurrent respiratory infections
Frequent episodes of respiratory tract infections such as bronchitis, pneumonia, or sinusitis due to compromised immune function.
Seek immediate care if experiencing difficulty breathing, high fever, or chest pain
Neurological symptoms
Various neurological manifestations including numbness, tingling, or cognitive difficulties due to immune-mediated nerve involvement.
Seek immediate care if experiencing sudden weakness, vision changes, or confusion
Persistent fatigue
(constitutional)Persistent feeling of tiredness and weakness that does not improve with rest, often due to immune system dysfunction.
Frequency: 70-80% of patients
Unexplained fever
(constitutional)Persistent or recurrent fever without obvious infection source, often indicating underlying immune abnormality.
Frequency: 40-50% of patients
Lymphadenopathy
(constitutional)Enlarged lymph nodes, typically in the neck, armpits, or groin, often indicating immune system activation.
Frequency: 35-45% of patients
Unintentional weight loss
(constitutional)Significant weight loss without dietary changes, often associated with chronic illness and metabolic disturbances.
Frequency: 30-40% of patients
Night sweats
(constitutional)Excessive sweating during sleep that may soak bedding, often associated with immune system abnormalities.
Frequency: 25-35% of patients
Skin rash or lesions
(dermatologic)Various skin manifestations including rashes, lesions, or unusual patches that may indicate immune-mediated skin involvement.
Frequency: 20-30% of patients
Chronic diarrhea
(gastrointestinal)Persistent diarrhea lasting more than four weeks, which may indicate gastrointestinal involvement or opportunistic infection.
Frequency: 15-20% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
CD4/CD8 ratio surveillance
Regular monitoring of CD4 and CD8 T-cell counts and ratios to track immune status and identify significant changes requiring intervention.
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Condition-specific immunotherapy
Targeted immunosuppressive or immunomodulatory treatment when the abnormal ratio is linked to autoimmune disease, infection, or immune deficiency.
Additional treatment options
Immune-supportive nutrition
Balanced diet emphasizing fruits, vegetables, lean proteins, and essential micronutrients to support healthy lymphocyte development and function.
dietaryInfection prevention strategies
Enhanced hygiene practices, vaccination as appropriate, and avoidance of sick contacts to protect compromised immune function.
lifestyleAdjunctive immune support
Complementary approaches including vitamin D supplementation, probiotics for gut immune health, and botanical immunomodulators.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Cd4 Cd8 Ratio C4531154?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
CDC. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. 2024.
WHO. Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring. 2021.
McCune JM. The CD4/CD8 ratio: new insights into its clinical utility. Clin Immunol. 2022;245:109125.
Serrano-Villar S, et al. The CD4/CD8 ratio in HIV infection: the key to immune restoration. Curr Opin HIV AIDS. 2019;14(3):197-203.
Buggert M, et al. CD4/CD8 ratio as a marker of immune activation and clinical outcomes in HIV infection. J Infect Dis. 2021;223(5):831-840.
International AIDS Society-USA Panel. Antiretroviral drugs for treatment and prevention of HIV infection in adults. JAMA. 2023;330(16):1562-1583.
Yang X, et al. CD4/CD8 ratio recovery in HIV patients following ART initiation. Clin Infect Dis. 2020;71(7):e207-e214.
American Academy of Allergy, Asthma and Immunology. Primary immunodeficiency evaluation and management guidelines. J Allergy Clin Immunol Pract. 2021;9(9):3204-3219.
Abbas AK, et al. Cellular and Molecular Immunology. 10th ed. Elsevier; 2022.
European AIDS Clinical Society. EACS Guidelines 2023. Version 12.0.
Medication Comparisons
Compare medications used to treat Abnormal Cd4 Cd8 Ratio C4531154. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy